Alliance for Genomic Discovery announces its five founding biopharma members . The AGD aims to accelerate drug development and expand the diversity of genomic data . The five founding members of the Alliance for Genomic Discovery (AGD), a project aiming to accelerate therapeutic development and expand the diversity of genomic data, have been announced. Joining the AGD are AstraZeneca, AbbVie, Amgen, Bayer and Merck, who will co-fund the whole-genome sequencing of 250,000 sample...